Our Company

Garrix Pharma Private Limited company has innovated Pharmaceutical realities in ever growing Remedial parts to feed Croakers in the field of Pediatrics, Gynecologic, General Medicine, Orthopedics, ENT, Dentistry & General Physicians.

At A Glance

Garrix Pharma Private Limited embodies a very human spirit by always remaining at the forefront to introduce Life Drugs in India at very affordable prices.

Our strong Belief & Vision of perfecting lives have been put into action by continually seeking to find new ways of doing all the effects we do. New ways that echo the requirements & bournes of a new progressive World. A World where people suppose out of the box, about life & work out effective results to demanding problems. A world where people want to be the most Stylish that they can be, despite all odds.

Garrix Pharma had taken birth on 28 July 2020, in the fiscal Capital Delhi, leading its incursion into manufacturing & marketing of a wide range of remedial phrasings time after time. Garrix Pharma has surfaced as one of the Country’s most reputed Pharmaceutical Company and also is the fastest growing Pharma Corporate amongst 100 Pharma Companies as reported by IMS July 2019.

Products

0 +

Patents

Employees

0 +

Countries

Our Company

Fast Growing Pharma Company

We’re passionate about creating accessible, affordable alternatives to high-priced prescription drugs. Our goal is to help Indian patients get the medicine they need—and we believe that’s possible through our cutting-edge technology and safe clinical trials.

Pharmaceuticals are a key component of healthcare, but they can be expensive. We are committed to providing affordable medicine and tablets to hospitals and clinics around the world.

Sudhakar Mishra

Founder, CEO of Garrix Pharma

Therapeutic Areas of Focus

Neurology and Oncology

Neuro-oncology is the study of brain and spinal cord neoplasms, many of which are (at least eventually) very dangerous and life-threatening (astrocytoma, glioma, glioblastoma multiforme, ependymoma, pontine glioma, and brain stem tumours are among the many examples of these).

Among the malignant brain cancers, gliomas of the brainstem and pons, glioblastoma multiforme, and high-grade (highly anaplastic) astrocytoma/oligodendroglioma are among the worst.^[1] In these cases, untreated survival usually amounts to only a few months, and survival with current radiation and chemotherapy treatments may extend that time from around a year to a year and a half, possibly two or more, depending on the patient’s condition, immune function, treatments used, and the specific type of malignant brain neoplasm. Surgery may in some cases be curative, but, as a general rule, malignant brain cancers tend to regenerate and emerge from remission easily, especially highly malignant cases. In such cases, the goal is to excise as much of the mass (tumor cells) and as much of the tumor margin as possible without endangering vital functions or other important cognitive abilities.